Updated on 7 January 2014
The company is aiming to bring the sales of its hand-held wheeze monitor for asthma sufferers into the main focus now
Singapore: In a bid to shift its focus from technology development to sales, Australia's top medical device manufacturer iSonea has made changes to its board and executive team.
The company is aiming to bring the sales of its hand-held wheeze monitor for asthma sufferers into the main focus now.
The company's vice-chairman Mr Ross Haghighat will succeed the chairman Mr Stewart Washer, who would be stepping down from the board.
Mr Jerry Korten who was formerly with GE, will take on the role of the chief executive following Mr Michael Thomas' retirement in November.
Acrux director and former Asia Pacific president of pharmaceutical outfit Hospira, Dr Tim Oldham, will also join the board. Mr Haghighat, who runs Boston-based private equity firm Triton Systems, said the changes in the top levels of iSonea were positive.